Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostaglandins.

J W Aiken

    Journal of Cardiovascular Pharmacology
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Prostaglandins significantly impact arteries by interacting with specific receptors. Endogenous prostaglandins modulate vasoactive hormones and can be formed through cell-to-cell interactions, influencing vascular tone.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Tröger's base. An alternate synthesis and a structural analog with thromboxane A2 synthetase inhibitory activity.

    Journal of medicinal chemistry·1993
    Same author

    Triazolobenzodiazepines: a new class of stimulators of tissue-type plasminogen activator synthesis in human endothelial cells.

    Biochemical pharmacology·1993
    Same author

    Effects of low doses of aspirin and dipyridamole on platelet aggregation in the dog coronary artery.

    The Journal of pharmacology and experimental therapeutics·1987
    Same author

    Thromboxane A2 synthase inhibitors. 5-(3-Pyridylmethyl)benzofuran-2-carboxylic acids.

    Journal of medicinal chemistry·1986
    Same author

    Effect of pulmonary and renal circulations on activity of atrial natriuretic factor.

    The American journal of physiology·1985
    Same author

    Pharmacological analysis of factors influencing platelet aggregation in stenosed coronary arteries of dogs.

    Annals of the New York Academy of Sciences·1985
    Same journal

    Integration of Mendelian Randomization and FAERS Database Analysis Reveals the Association Between Ergotamine and Aortic and Mitral Valve Diseases.

    Journal of cardiovascular pharmacology·2026
    Same journal

    A Comprehensive Review of PCSK9 Inhibitor Therapy.

    Journal of cardiovascular pharmacology·2026
    Same journal

    SGLT2 Inhibitors and Progression of Chronic Kidney Disease in Patients with Elevated Lipoprotein(a): A Real-World Cohort Study.

    Journal of cardiovascular pharmacology·2026
    Same journal

    Aspirin in primary prevention: a case for selective use.

    Journal of cardiovascular pharmacology·2026
    Same journal

    GLP-1 Gene Therapy Trial for Obesity and Type 2 Diabetes: Towards a New Paradigm for Chronic Disease Treatment.

    Journal of cardiovascular pharmacology·2026
    Same journal

    Expert Opinion: Restrictions, Precautions, or Normalcy? Defining Everyday Risk in Patients Treated With IL-1 Blockers for Recurrent Pericarditis.

    Journal of cardiovascular pharmacology·2026
    See all related articles

    Area of Science:

    • Vascular Biology
    • Pharmacology

    Background:

    • Prostaglandins play a crucial role in regulating vascular tone.
    • Understanding prostaglandin receptors and their signaling pathways is essential for cardiovascular research.

    Purpose of the Study:

    • To discuss the multifaceted effects of prostaglandins on arteries.
    • To explore the roles of prostaglandin receptors, endogenous modulation, and cell-cell interactions in vascular function.

    Main Methods:

    • Review of existing evidence on prostaglandin receptors (vasodilator: PGE2, PGI2; vasoconstrictor: TXA2).
    • Analysis of the modulatory effects of endogenous prostaglandins on vasoactive hormones like angiotensin II and bradykinin.
    • Examination of substrate transfer and metabolite formation via cell-cell interactions (platelets, leukocytes, endothelium, smooth muscle).

    Related Experiment Videos

    Main Results:

    • Evidence supports at least two vasodilator prostaglandin receptors (PGE2, PGI2) and one vasoconstrictor receptor (TXA2).
    • Endogenous vasodilator prostaglandins can attenuate angiotensin II's vasoconstriction and mediate bradykinin's vasodilation.
    • Interactions between blood cells and the vessel wall are a key source of vasoactive metabolites, with potential for therapeutic manipulation (e.g., thromboxane synthetase inhibition).

    Conclusions:

    • Prostaglandins exert complex effects on arteries through distinct receptors and endogenous modulation.
    • Cell-to-cell communication within the vasculature is critical for generating vasoactive arachidonic acid metabolites.
    • Further research into these interactions may uncover novel therapeutic targets for vascular diseases.